Correction to Lancet Respir Med 2020; 8: 963-74
- PMID: 33007286
- DOI: 10.1016/S2213-2600(20)30423-9
Correction to Lancet Respir Med 2020; 8: 963-74
Erratum for
-
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
